Furthermore, HT use decreases vasomotor symptoms during the menopause transition which can lead to improved sleep, increased activity, and overall increased quality of life, all factors that can further mitigate the changes in body composition experienced during menopause
Generally, the best candidates are women under the age of 60 or within 10 years of menopause onset who have bothersome symptoms, and don't have contraindications to systemic hormone therapy (which include a history of blood clots and certain types of cancer, like breast cancer), according to Faubion
its one of the longest-running longevity clinics in the world
A key question that remains to be answered is which drugs and which brain targets will maximize the neuroprotective benefits while minimizing adverse events
A few individuals could experience headaches or dizziness